Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Chunjian, Qi"'
Autor:
Qian Geng, Yingying Lu, Dongqing Li, Lanqun Qin, Chunjian Qi, Xiaolin Pu, Yi Zhuang, Yajun Zhu, Quanbin Zha, Ge Wang, Hua Jiang
Publikováno v:
BMC Immunology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Immune checkpoint inhibitor rechallenge has emerged as a prominent study area in non-small cell lung cancer (NSCLC). β-glucan was reported to reverse resistance to anti-PD-1/PD-L1 inhibitors by regulating the tumor microenvironme
Externí odkaz:
https://doaj.org/article/531eeef188b043d9b414285c708b86aa
Autor:
Yuan Qi, Mengjie Wang, Ya Xue, Jingyan Yue, Chunjian Qi, Weihu Shang, Weifen Meng, Wenyu Zhu, Xiaolin Pu, Dongqing Li, Hua Jiang
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Objective Explore the feasibility of a mobile health(mHealth) and virtual reality (VR) based nutrition-exercise-psychology integrated rehabilitation model in Chinese cancer patients. Methods We recruited cancer patients in the Oncology depar
Externí odkaz:
https://doaj.org/article/5929a4f1def140c18e4e06db76264722
Autor:
Yunqian Chu, Xuan He, Ya Xue, Hua Jiang, Chan Zhu, Chunjian Qi, Xing Zhang, Dongsheng Chen, Hanjue Dai, Qingying Xian, Wenyu Zhu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Backgroundβ-glucan has been reported to be a potential natural immune modulator for tumor growth inhibition. We aimed to evaluate the efficacy and safety of β-glucan plus immunotherapy and chemotherapy in the first-line treatment of advanced gastri
Externí odkaz:
https://doaj.org/article/df74eeb7399f45249cbc832d53ddb9bb
Publikováno v:
Immunity, Inflammation and Disease, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract Background Particulate β‐glucans (WGP) are natural compounds with regulatory roles in various biological processes, including tumorigenesis and inflammatory diseases such as allergic asthma. However, their impact on mast cells (MCs), cont
Externí odkaz:
https://doaj.org/article/12fd9814d78b44a5a0bb7bdca0aee5e9
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveTo investigate the association of serum uric acid (SUA) with all-cause and cardiovascular death in individuals with coronary heart disease (CHD).MethodsIn this prospective cohort study, 1556 individuals from the National Health and Nutrition
Externí odkaz:
https://doaj.org/article/9e5e83228e304790904cedfff45b01ea
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Background and aimsIncreasing evidence supports a causal relationship between lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease, yet its association with left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) remains u
Externí odkaz:
https://doaj.org/article/cc48779b39ee4a299cab8f3ba6bc55c5
Autor:
Lifeng Zhang, Shenglin Gao, Xiaokai Shi, Yin Chen, Shuzhang Wei, Yuanyuan Mi, Li Zuo, Chunjian Qi
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7149-7163 (2023)
Abstract Background NUPR1, or p8, is a small chromatin protein that plays a central role in the resistance to treatment and progression of cancer. Nevertheless, the molecular mechanism of NUPR1 in bladder cancer (BLCA) remains unclear. Methods We use
Externí odkaz:
https://doaj.org/article/3fa7215846ae480e9f0b2dcffb6dc3dc
Autor:
Yewen Xie, Fang Shao, Xuehan Duan, Jun Ding, Yongling Ning, Xiao Sun, Lei Xia, Jie Pan, Jie Chen, Shuyan He, Dong Shen, Chunjian Qi
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Yeast β-glucan is a polysaccharide purified from the Saccharomyces cerevisiae cell wall, and its multiple biological activities are essential for immune regulation. However, the effect of β-glucan on the intestinal immune response during colitis-as
Externí odkaz:
https://doaj.org/article/d73a7465fa0b4352abe2b818af7ee94a
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/1ca30b8ef39e4a64b95fa2619d8df218
Autor:
Mengjie Wang, Yu Bai, Jiaxin Pei, Dongqing Li, Xiaolin Pu, Wenyu Zhu, Lei Xia, Chunjian Qi, Hua Jiang, Yongling Ning
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Programmed death-1 (PD-1)/PD-ligand 1 (PD-L1) checkpoint blocking antibodies have been shown to be a powerful immune checkpoint blockade (ICB) therapy for patients with cancer. However, patients quickly develop resistance to immunotherapy. β-glucan,
Externí odkaz:
https://doaj.org/article/bf87ace5565440f2a46d79d819ee3ef2